Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRNS Marinus Pharmaceuticals

盘前交易 12-19 04:40:36 EST

0.2436

-0.0034

-1.38%

最高0.2565	最低0.2420	成交量377.21万
今开0.2500	昨收0.2470	日振幅5.87%
总市值1,344万	流通市值974.01万	总股本5,519万
成交额93.41万	换手率9.43%	流通股本3,998万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRNS","market":"US","secType":"STK","nameCN":"Marinus Pharmaceuticals","latestPrice":0.2436,"timestamp":1734555600000,"preClose":0.247,"halted":0,"volume":3772094,"delay":0,"floatShares":39984146,"shares":55185622,"eps":-2.466183,"marketStatus":"盘前交易","marketStatusCode":1,"change":-0.0034,"latestTime":"12-19 04:40:36 EST","open":0.25,"high":0.256499,"low":0.242,"amount":934071.03842604,"amplitude":0.0587,"askPrice":0.2987,"askSize":100,"bidPrice":0.2224,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.466183,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734618600000},"adr":0,"listingDate":1406779200000,"adjPreClose":0.2436,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":0.2527,"preClose":0.2436,"latestTime":"19:55 EST","volume":3291090,"amount":801795.069,"timestamp":1734569726651},"volumeRatio":3.6879602509763623,"impliedVol":0.1888,"impliedVolPercentile":0.1076},"requestUrl":"/m/hq/s/MRNS","defaultTab":"news","newsList":[{"id":"2491697860","title":"Marinus Pharmaceuticals, Inc.股价重挫10.12% 市值跌63.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491697860","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491697860?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:44","pubTimestamp":1734360279,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时44分，Marinus Pharmaceuticals, Inc.股票出现异动，股价大幅下挫10.12%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.53%。其相关个股中，Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Viridian Therapeutics, Inc.涨幅较大，Tonix Pharmaceuticals Holding Corp.、Dermata Therapeutics, Inc.、Genprex, Inc.较为活跃，换手率分别为38.99%、32.73%、30.20%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Tonix Pharmaceuticals Holding Corp.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为38.10%、19.33%、19.23%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224439ab7c9ace&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216224439ab7c9ace&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2491617374","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅跳水5.03%报0.259美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491617374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491617374?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:36","pubTimestamp":1734104201,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时36分，Marinus Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.03%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Oculis Holding Ag C/Wts 06/03/2028 、Cardiff Oncology, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为56.16%、50.09%、33.09%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为43.30%、43.12%、39.33%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213233641984bd9c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241213233641984bd9c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2490438075","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速跳水6.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490438075","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490438075?lang=zh_cn&edition=full","pubTime":"2024-12-12 22:59","pubTimestamp":1734015579,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日22时59分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速跳水6.69%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。其相关个股中，Palisade Bio, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Trevi Therapeutics, Inc.涨幅较大，Palisade Bio, Inc.、Aptevo Therapeutics Inc.、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为2984.20%、723.75%、64.78%，振幅较大的相关个股有Palisade Bio, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Aptevo Therapeutics Inc.，振幅分别为56.43%、55.45%、37.26%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121222593995e93819&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121222593995e93819&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2490127600","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490127600","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490127600?lang=zh_cn&edition=full","pubTime":"2024-12-10 23:18","pubTimestamp":1733843890,"startTime":"0","endTime":"0","summary":"北京时间2024年12月10日23时18分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.19%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.39%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Uniqure N.V.涨幅较大，Psyence Biomedical Ltd.、Processa Pharmaceuticals, Inc.、Chimerix, Inc.较为活跃，换手率分别为1902.13%、436.00%、110.00%，振幅较大的相关个股有Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Psyence Biomedical Ltd.，振幅分别为150.29%、131.78%、38.65%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023181195e8b0c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121023181195e8b0c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2489319258","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.24%报0.295美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489319258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489319258?lang=zh_cn&edition=full","pubTime":"2024-12-07 00:19","pubTimestamp":1733501963,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日00时19分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.24%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Psyence Biomedical Ltd C/Wts 25/01/2029、Adc Therapeutics Sa涨幅较大，Psyence Biomedical Ltd.、Molecular Templates, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为125.23%、71.85%、57.68%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Cervomed Inc.、Adc Therapeutics Sa，振幅分别为190.28%、41.15%、40.01%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207001924a1d9a467&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207001924a1d9a467&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2489463081","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.45%报0.288美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489463081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489463081?lang=zh_cn&edition=full","pubTime":"2024-12-05 23:16","pubTimestamp":1733411799,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日23时16分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.45%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Psyence Biomedical Ltd.、Molecular Templates, Inc.、Protara Therapeutics, Inc.较为活跃，换手率分别为2192.88%、765.41%、352.70%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为109.61%、92.09%、84.26%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120523163998e5a07b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120523163998e5a07b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2488492019","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘快速跳水5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488492019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488492019?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:49","pubTimestamp":1733237384,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时49分，Marinus Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.47%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.45%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Senti Biosciences, Inc.较为活跃，换手率分别为133.65%、84.04%、76.49%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Coherus Biosciences, Inc.、Senti Biosciences, Inc.，振幅分别为51.13%、37.96%、28.70%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120322494498e51cab&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120322494498e51cab&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2486337630","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486337630","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486337630?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:54","pubTimestamp":1732546476,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时54分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.69%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.18%。其相关个股中，Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为93.97%、85.21%、51.22%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Citius Pharmaceuticals, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为61.31%、36.25%、34.34%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125225436abde05e5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125225436abde05e5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2485428473","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485428473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485428473?lang=zh_cn&edition=full","pubTime":"2024-11-22 04:57","pubTimestamp":1732222652,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日04时57分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.02%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Briacell Therapeutics Corp.涨幅较大，Biodexa Pharmaceuticals Plc、Conduit Pharmaceuticals Inc.、Tff Pharmaceuticals, Inc.较为活跃，换手率分别为995.69%、552.22%、417.91%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Biodexa Pharmaceuticals Plc，振幅分别为162.20%、87.47%、84.16%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112204573298e44000&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112204573298e44000&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2484067073","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘大幅上涨6.00%报0.320美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484067073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484067073?lang=zh_cn&edition=full","pubTime":"2024-11-18 23:59","pubTimestamp":1731945564,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日23时59分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速拉升6.00%。截至发稿，该股报0.320美元/股，成交量39.3001万股，换手率0.71%，振幅6.26%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235924abccd35b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118235924abccd35b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2483864048","title":"Marinus Pharmaceuticals, Inc.2024财年第三财季实现净利润-24.23百万美元，同比增加26.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483864048","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483864048?lang=zh_cn&edition=full","pubTime":"2024-11-14 08:00","pubTimestamp":1731542419,"startTime":"0","endTime":"0","summary":"11月14日，Marinus Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-24.23百万美元，同比增加26.51%；其中营业收入为8.54百万美元，同比增加16.35%，每股基本收益为-0.42美元。机构评级：截至2024年11月14日，当前有6家机构对Marinus Pharmaceuticals, Inc.目标价做出预测，其中目标均价为1.83美元，其中最低目标价为0.50美元，最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080020a2355865&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114080020a2355865&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS"],"gpt_icon":0},{"id":"2483243881","title":"Marinus Pharmaceuticals, Inc.盘中异动 大幅下跌8.38%报0.316美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483243881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483243881?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:32","pubTimestamp":1731508336,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时32分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅跳水8.38%。截至发稿，该股报0.316美元/股，成交量6.9605万股，换手率0.13%，振幅2.15%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Mersana Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为329.62%、174.16%、84.72%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Mersana Therapeutics, Inc.、Lexeo Therapeutics, Inc.，振幅分别为14.89%、10.27%、9.75%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223216a2345422&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223216a2345422&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2481101713","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481101713","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481101713?lang=zh_cn&edition=full","pubTime":"2024-11-08 22:43","pubTimestamp":1731076995,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日22时43分，Marinus Pharmaceuticals, Inc.股票出现波动，股价大幅下跌5.60%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.51%。其相关个股中，Matinas Biopharma Holdings, Inc.、Fortrea Holdings Inc.、Inhibikase Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Matinas Biopharma Holdings, Inc.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为449.83%、30.24%、18.84%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Matinas Biopharma Holdings, Inc.，振幅分别为86.00%、31.72%、23.50%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224315971a5612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108224315971a5612&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2481493709","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大涨5.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481493709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481493709?lang=zh_cn&edition=full","pubTime":"2024-11-07 03:20","pubTimestamp":1730920835,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日03时20分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.62%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.79%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为3373.67%、505.53%、152.44%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Cardio Diagnostics Holdings Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为128.03%、82.72%、59.87%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107032035aba737de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107032035aba737de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2480058584","title":"Marinus Pharmaceuticals, Inc.盘中异动 急速下挫5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058584","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058584?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:56","pubTimestamp":1730732185,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时56分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.28%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.08%。其相关个股中，Neurogene Inc.、Disc Medicine, Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为256.46%、210.05%、56.09%，振幅较大的相关个股有Tc Biopharm  Plc C/Wts 10/02/2028 、Briacell Therapeutics Corp C/Wts 24/02/2025、Nls Pharmaceutics Ltd.，振幅分别为31.90%、29.83%、25.56%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225625ab9eca44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104225625ab9eca44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","MRNS"],"gpt_icon":0},{"id":"2480884495","title":"Marinus Pharmaceuticals Inc   预计每股亏损41美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480884495","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480884495?lang=zh_cn&edition=full","pubTime":"2024-11-01 22:14","pubTimestamp":1730470461,"startTime":"0","endTime":"0","summary":"   * Marinus Pharmaceuticals Inc    预计将在11月5日公布截至0001年1月1日的业绩报告(预计)，季度收入将有所增长。* 根据LSEG的数据，10位分析师的平均预期显示，这家总部位于宾夕法尼亚州Radnor的公司的营收预计将从去年同期的734万美元增长28.3%，达到941.8万美元。* LSEG分析师对Marinus Pharmaceuticals Inc的平均预期是每股亏损41美分。* 华尔街对 Marinus Pharmaceuticals Inc 的 12 个月目标价中位数为 2.00 美元，高于上一次收盘价 0.30 美元。11月1日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Marinus Pharmaceuticals Inc   预计每股亏损41美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNS"],"gpt_icon":0},{"id":"2480066409","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.11%报0.303美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480066409","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480066409?lang=zh_cn&edition=full","pubTime":"2024-11-01 03:56","pubTimestamp":1730404580,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日03时56分，Marinus Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.11%。截至发稿，该股报0.303美元/股，成交量259.281万股，换手率4.71%，振幅6.33%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.91%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035620971a3a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101035620971a3a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2479283321","title":"Marinus Pharmaceuticals, Inc.盘中异动 股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479283321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479283321?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:35","pubTimestamp":1730208926,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日21时35分，Marinus Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.41%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.14%。其相关个股中，Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.、Glycomimetics, Inc.较为活跃，换手率分别为551.79%、256.22%、143.71%，振幅较大的相关个股有Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Coya Therapeutics, Inc.，振幅分别为54.10%、25.95%、17.17%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213526a1f5a2d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029213526a1f5a2d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2478486055","title":"Marinus Pharmaceuticals, Inc.盘中异动 早盘大幅下挫5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478486055","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478486055?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:30","pubTimestamp":1730122221,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时30分，Marinus Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.46%。Marinus Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Revance Therapeutics, Inc.、Immunitybio, Inc.涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为534.84%、47.79%、35.84%，振幅较大的相关个股有Matinas Biopharma Holdings, Inc.、Avid Bioservices, Inc.、Nrx Pharmaceuticals, Inc.，振幅分别为4.31%、3.90%、3.31%。Marinus Pharmaceuticals, Inc.公司简介：Marinus Pharmaceuticals Inc 是一家临床阶段的生物制药公司。Marinus 管理一个部门的业务，即神经精神疗法的识别和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821302198e3eccc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102821302198e3eccc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRNS","BK4007"],"gpt_icon":0},{"id":"2478789336","title":"美国研究综述-Appfolio、标普全球、优步","url":"https://stock-news.laohu8.com/highlight/detail?id=2478789336","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478789336?lang=zh_cn&edition=full","pubTime":"2024-10-25 14:47","pubTimestamp":1729838867,"startTime":"0","endTime":"0","summary":"    路透10月25日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Appfolio、标普全球和优步。要闻             * Appfolio Inc   ：Piper Sandler将目标价从300美元下调至265美元             * Marinus Pharmaceuticals Inc   ：TD Cowen将目标价从买入下调至持有             * 纽蒙特   ：丰业银行将其评级从 \"跑赢大市 \"下调至 \"行业表现\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0d7308f866f3de0fe4454f56a883ee8f","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","AIT","PRGS","BK4529","LU1003077747.HKD","DXCM","HON","MRNS","BK4082","BK4104","FCNCA","LU0787776722.HKD","IE00BZ199S13.USD","TPR","APPF","IE0004445015.USD","MOH","DECK","BK4535","LYFT","NDAQ","NEM","SPGI","KDP","TYL","BK4097","LU0788108826.HKD","EW","LU0788109121.HKD","UPS","LU2210150020.SGD","LU0719512351.SGD","CVLG","HAS","LU0310800965.SGD","NEP","SKX","UNP","LU0127658192.USD","LU1861214812.USD","UCB","LU0868494617.USD","PEGA","LU1989764664.SGD","LU1989763690.USD","BK4551","DLR","UBER","BK4504","LU0300736492.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.marinuspharma.com","stockEarnings":[{"period":"1week","weight":-0.1506},{"period":"1month","weight":-0.2091},{"period":"3month","weight":-0.8478},{"period":"6month","weight":-0.8168},{"period":"1year","weight":-0.9742},{"period":"ytd","weight":-0.9776}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Marinus Pharmaceuticals, Inc.于2003年8月14日在特拉华州成立。该公司是一家临床阶段生物制药公司，专注于开发创新性神经精神疗法并将其商业化。该公司的临床阶段候选产品甘纳索龙是一种小分子，它是异孕烯醇的合成类似物，异孕烯醇是一种在中枢神经系统中产生的内源性神经甾体，调节大脑神经递质γ-氨基丁酸（GABA）。该公司对加那索龙的主要适应症是作为一种辅助或附加疗法，用于治疗成人癫痫患者部分发作（也称为局灶性发作）。该公司已在147名局灶性发作癫痫患者中完成了一项2期临床试验，表明与添加安慰剂的患者相比，在用药方案中添加加那索龙的患者癫痫发作率显著降低。Marinus Pharmaceuticals目前正在招募患者参加一项随机的2b期临床试验，该公司打算扩大该试验，以便在向美国食品和药物管理局（FDA）或欧洲药品管理局（EMA）提交的关于加那索龙治疗癫痫的注册文件中，作为其充分且受控的临床试验之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.037828},{"month":2,"riseRate":0.6,"avgChangeRate":-0.012045},{"month":3,"riseRate":0.5,"avgChangeRate":0.033633},{"month":4,"riseRate":0.5,"avgChangeRate":-0.069609},{"month":5,"riseRate":0.5,"avgChangeRate":-0.007141},{"month":6,"riseRate":0.5,"avgChangeRate":0.034813},{"month":7,"riseRate":0.6,"avgChangeRate":0.022118},{"month":8,"riseRate":0.454545,"avgChangeRate":0.029644},{"month":9,"riseRate":0.636364,"avgChangeRate":0.195949},{"month":10,"riseRate":0.272727,"avgChangeRate":-0.205727},{"month":11,"riseRate":0.454545,"avgChangeRate":0.029632},{"month":12,"riseRate":0.545455,"avgChangeRate":0.089552}],"exchange":"NASDAQ","name":"Marinus Pharmaceuticals","nameEN":"Marinus Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Marinus Pharmaceuticals,MRNS,Marinus Pharmaceuticals股票,Marinus Pharmaceuticals股票老虎,Marinus Pharmaceuticals股票老虎国际,Marinus Pharmaceuticals行情,Marinus Pharmaceuticals股票行情,Marinus Pharmaceuticals股价,Marinus Pharmaceuticals股市,Marinus Pharmaceuticals股票价格,Marinus Pharmaceuticals股票交易,Marinus Pharmaceuticals股票购买,Marinus Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Marinus Pharmaceuticals(MRNS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Marinus Pharmaceuticals(MRNS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况